companydata.dkMCNEIL DENMARK ApS
CVR: 30077008
Secondary names: McNeil Esbjerg ApS;, Scan-Gum ApS, Pharmacia Esbjerg ApS
The financial health of MCNEIL DENMARK ApS appears stable, with consistent revenue generation and profitability over recent years. In 2024, the company reported revenue of 479.14 million DKK and a profit of 14.58 million DKK, reflecting a slight decline in revenue from 2023 but an increase in profit. Equity has significantly improved from 27.32 million DKK in 2022 to 56.28 million DKK in 2024, indicating a strengthening balance sheet. While profit margins have fluctuated, the overall trend shows resilience, positioning the company favorably within the medicinal and healthcare wholesale industry. However, the stability of revenue and profit in the face of slight declines may warrant monitoring for future growth opportunities.
AI-generated summary
Overview
Details
Contact
Advertising protectedPurpose
Selskabets formål er at drive virksomhed indenfor handel og industri.
Location
Financials
| Year | Revenue | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 2024 | 479.1 mio. | 14.6 mio. | 150.6 mio. | 56.3 mio. | 18 | |
History
Ownership
Management
Directors
Production units (1)
Similar companies
Companies in the same industry and area